(Q36404698)

14 August 2017

Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia (English)

1 reference

14 August 2017

1 reference

Mehdi Hamadani

22

0 references

Vikas Gupta

object named as

Vikas Gupta

25

0 references

Jorge Eduardo Cortes

17

object named as

Jorge Cortes

1 reference

14 August 2017

26

H Joachim Deeg

1 reference

14 August 2017

19

Joseph Antin

1 reference

14 August 2017

13

Harry C Schouten

1 reference

14 August 2017

10

David L Porter

1 reference

14 August 2017

2

Ann E Woolfrey

1 reference

14 August 2017

24

Steven Pavletic

1 reference

14 August 2017

Karen K Ballen

1

1 reference

14 August 2017

Xiaochun Zhu

3

1 reference

14 August 2017

Kwang Woo Ahn

4

1 reference

14 August 2017

Baldeep Wirk

5

1 reference

14 August 2017

Mukta Arora

6

1 reference

14 August 2017

Biju George

7

1 reference

14 August 2017

Bipin N Savani

8

1 reference

14 August 2017

Brian Bolwell

9

1 reference

14 August 2017

Ed Copelan

11

1 reference

14 August 2017

Gregory Hale

12

1 reference

14 August 2017

Ian Lewis

14

1 reference

14 August 2017

Jean Yves Cahn

15

1 reference

14 August 2017

Joerg Halter

16

1 reference

14 August 2017

Matt E Kalaycio

18

1 reference

14 August 2017

Mahmoud D Aljurf

20

1 reference

14 August 2017

Matthew H Carabasi

21

1 reference

14 August 2017

Philip McCarthy

23

1 reference

14 August 2017

Richard T Maziarz

27

1 reference

14 August 2017

Mary M Horowitz

28

1 reference

14 August 2017

Wael Saber

29

1 reference

14 August 2017

24 March 2012

1 reference

Biology of Blood and Marrow Transplantation

14 August 2017

1 reference

14 August 2017

18

1 reference

14 August 2017

9

1 reference

14 August 2017

1446-1454

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

14 August 2017

1 reference

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Evidence and expertise in the management of polycythemia vera and essential thrombocythemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

A gain-of-function mutation of JAK2 in myeloproliferative disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Syngeneic stem cell transplant for spent-phase polycythaemia vera: eradication of myelofibrosis and restoration of normal haematopoiesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

The indolent natural history of essential thrombocythemia: a challenge to new drug development

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Quantification of the completeness of follow-up.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499973

Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial

21 September 2018

1 reference

12 December 2020

Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation

1 reference

12 December 2020

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

12 December 2020

Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis

1 reference

12 December 2020

Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia

1 reference

12 December 2020

Interferon alpha therapy for patients with essential thrombocythemia: final results of a phase II study initiated in 1986

1 reference

12 December 2020

Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status

1 reference

12 December 2020

Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients

1 reference

12 December 2020

Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia

1 reference

12 December 2020

Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients

1 reference

12 December 2020

The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis

1 reference

12 December 2020

Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation

1 reference

12 December 2020

Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis

1 reference

12 December 2020

10.1016/J.BBMT.2012.03.009

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22449610

1 reference